Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessCNBC-TV18 CommentsLupin, Mylan set to duel in US courts for Antara control

SHOW NAMES

Trending Topics

business

Lupin, Mylan set to duel in US courts for Antara control

CNBC-TV18‘s Archana Shukla reports there could some rough sailing for Lupin as one of its key US brands â€“ anti-cholesterol drug Antara - faces threat from competition from generic rivals with the USFDA (United States Food and Drug Administration) having granted final approval to Mylan's generic version of Antara

first published: Jan 14, 2013 10:17 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347